Impact Factor
4.77
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
13.88
3,378 total citations
h5-index
76
h5 depth signal
Cited share
96.9%
253 of 261
Total citations
3,378
Citation footprint
Metric signal
16.47
External metric anchor
Self-citation
1.7%
59 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
461
United States
284
United Kingdom
107
Germany
74
France
67
Citing Fields of Research
Bacteriology
545
Inflammatory Bowel Diseases & Infections
484
Genetics & Genomics
113
Antibiotic & Antibacterial Agents
101
Dentistry & Oral Medicine
75
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,201
Articles tracked across the journal lifetime
Indexed publication set
261
253 cited publications
Last 12 months
339
28.3 publications/month
Open access share
100.0%
339 OA publications in the last year
Leading citing country
China
461 citing publications
Leading citing field
Bacteriology
545 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v4, 2018-
v1, 2015-
Active Coverage
Research Focus & Classification
Indexed Subjects
Inflammatory Bowel Diseases & Infections
Bacteriology
Issuing & Sponsoring Bodies
publisher
Nanyang Technological University
publisher
Singapore Centre for Environmental Life Sciences Engineering
Broad Categories
Microbiology
Inflammatory Bowel Diseases & Infections
Bacteriology
Dentistry & Oral Medicine
Antibiotic & Antibacterial Agents
MeSH Descriptors
Biofilms
Microbiological Phenomena
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1038/s41522-026-01140-2
Open DOI
Recovering anaerobic bacterial genomes in saliva, tumour and blood whole genome sequencing data from patients with prostate cancer
Microbial constituents in the gastrointestinal tract, the urine and prostate tissue are being linked with clinical differences in prostate cancer, and a recent meta-analysis has linked periodontal disease to this cancer. Several hypothes...
02
DOI 10.1038/s41522-026-01175-5
Open DOI
Environmental cues shape mucosal enteric glia networks independent of lamina propria innervation
Mucosal enteric glia are implicated in different aspects of gut function but the determinants of their occupancy of the lamina propria remain obscure. Analyzing mucosal enteric glia during intestinal inflammation and in mouse models diff...
03
DOI 10.1038/s41522-026-01106-4
Open DOI
Lactobacillus agilis in the small intestine reduce abdominal fat deposition in broilers by regulating lipid metabolism
04
DOI 10.1038/s41522-026-01178-2
Open DOI
A validation framework for translating ethnomicrobiology into microbiome-enabled desert restoration
05
DOI 10.1038/s41522-026-01123-3
Open DOI
Nonlocal interactions through hydrodynamics drive biofilm development and microbial competition in porous media
Microorganisms predominantly exist within soil-like environments as sessile communities called biofilms, where fluid dynamics critically shape their development and dispersal. Despite their central role in diverse systems, from biogeoche...
06
DOI 10.1038/s41522-026-01172-8
Open DOI
G-quadruplex aptamer conjugate for the enhanced recognition and eradication of Staphylococcus aureus biofilms
Bacterial biofilm-associated infections remain a major challenge in clinical settings. Innovative solutions are therefore urgently needed to improve the efficacy of antibacterial agents and to overcome biofilm tolerance. In this study, w...
07
08
DOI 10.1038/s41522-026-01166-6
Open DOI
Stachyose ameliorates polycystic ovary syndrome through the gut–BAT axis by promoting Alistipes sp. proliferation
09
DOI 10.1038/s41522-026-01173-7
Open DOI
Biofilm matrix-mediated localization potentiates antimicrobial activity in cariogenic biofilms
10
DOI 10.1038/s41522-026-01170-w
Open DOI
Gut microbiome features in methamphetamine use disorder: external validation of a candidate marker panel and exploratory multi-omics associations
Methamphetamine use disorder (MUD) is a chronic, relapsing disorder with symptoms most pronounced during withdrawal, yet objective biomarkers remain lacking. Although gut microbial alterations have been reported in substance use disorder...
Bibliographical & Catalog Notes
Articles added as received during the year.